Metabolon Sues Stemina for Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – Metabolomics diagnostics and services company Metabolon has sued Stemina Biomarker Discovery alleging infringement of two patents, a month-and-a-half after Stemina filed a lawsuit asking a federal court to find that it does not infringe on two sets of patents held by Metabolon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.